Oncolytics Free Cash Flow vs Change To Account Receivables Analysis

ONC Stock  CAD 1.02  0.01  0.97%   
Oncolytics Biotech financial indicator trend analysis is much more than just breaking down Oncolytics Biotech prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Oncolytics Biotech is a good investment. Please check the relationship between Oncolytics Biotech Free Cash Flow and its Change To Account Receivables accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.

Free Cash Flow vs Change To Account Receivables

Free Cash Flow vs Change To Account Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Oncolytics Biotech Free Cash Flow account and Change To Account Receivables. At this time, the significance of the direction appears to have no relationship.
Free Cash FlowChange To Account ReceivablesDiversified AwayFree Cash FlowChange To Account ReceivablesDiversified Away100%
The correlation between Oncolytics Biotech's Free Cash Flow and Change To Account Receivables is 0.01. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Change To Account Receivables in the same time period over historical financial statements of Oncolytics Biotech, assuming nothing else is changed. The correlation between historical values of Oncolytics Biotech's Free Cash Flow and Change To Account Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Oncolytics Biotech are associated (or correlated) with its Change To Account Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change To Account Receivables has no effect on the direction of Free Cash Flow i.e., Oncolytics Biotech's Free Cash Flow and Change To Account Receivables go up and down completely randomly.

Correlation Coefficient

0.01
Relationship DirectionPositive 
Relationship StrengthInsignificant

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Change To Account Receivables

Most indicators from Oncolytics Biotech's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Oncolytics Biotech current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.At this time, Oncolytics Biotech's Selling General Administrative is very stable compared to the past year. As of the 24th of February 2025, Enterprise Value is likely to grow to about 118 M, while Tax Provision is likely to drop about 82.9 K.
 2022 2023 2024 2025 (projected)
Net Interest Income528K1.3M1.5M1.6M
Interest Income528K1.3M1.5M1.8M

Oncolytics Biotech fundamental ratios Correlations

0.30.020.880.72-0.85-0.65-0.180.83-0.150.99-0.190.730.520.750.70.40.681.0-0.470.36-0.11-0.490.130.070.72
0.30.370.250.58-0.37-0.340.40.24-0.690.330.22-0.11-0.03-0.090.230.170.030.35-0.730.23-0.49-0.67-0.64-0.170.2
0.020.37-0.290.290.01-0.160.54-0.02-0.39-0.020.33-0.080.08-0.020.20.640.10.04-0.420.22-0.15-0.41-0.290.60.01
0.880.25-0.290.52-0.8-0.37-0.10.72-0.050.92-0.350.470.160.470.37-0.050.410.88-0.30.22-0.17-0.260.04-0.210.44
0.720.580.290.52-0.6-0.77-0.180.54-0.230.680.030.540.570.570.660.60.540.73-0.610.67-0.06-0.64-0.230.170.69
-0.85-0.370.01-0.8-0.60.470.11-0.960.37-0.870.27-0.55-0.35-0.56-0.49-0.27-0.64-0.850.44-0.040.310.43-0.16-0.05-0.47
-0.65-0.34-0.16-0.37-0.770.470.35-0.510.36-0.59-0.09-0.8-0.81-0.8-0.94-0.71-0.74-0.660.7-0.4-0.020.8-0.030.0-0.9
-0.180.40.54-0.1-0.180.110.35-0.19-0.45-0.10.06-0.55-0.64-0.56-0.29-0.17-0.38-0.15-0.32-0.2-0.47-0.17-0.51-0.1-0.53
0.830.24-0.020.720.54-0.96-0.51-0.19-0.340.84-0.290.690.450.680.60.350.790.82-0.41-0.01-0.32-0.410.320.080.52
-0.15-0.69-0.39-0.05-0.230.370.36-0.45-0.34-0.2-0.130.010.010.02-0.34-0.22-0.21-0.190.840.350.490.780.380.21-0.1
0.990.33-0.020.920.68-0.87-0.59-0.10.84-0.2-0.310.660.410.670.640.30.640.99-0.480.28-0.18-0.470.10.00.65
-0.190.220.33-0.350.030.27-0.090.06-0.29-0.13-0.31-0.150.17-0.04-0.020.32-0.17-0.18-0.120.190.1-0.26-0.270.120.0
0.73-0.11-0.080.470.54-0.55-0.8-0.550.690.010.66-0.150.840.980.890.610.920.7-0.290.280.03-0.40.540.110.86
0.52-0.030.080.160.57-0.35-0.81-0.640.450.010.410.170.840.890.790.820.730.5-0.280.420.31-0.460.330.290.82
0.75-0.09-0.020.470.57-0.56-0.8-0.560.680.020.67-0.040.980.890.870.680.890.73-0.310.340.12-0.430.480.190.86
0.70.230.20.370.66-0.49-0.94-0.290.6-0.340.64-0.020.890.790.870.720.880.69-0.650.28-0.11-0.730.240.060.9
0.40.170.64-0.050.6-0.27-0.71-0.170.35-0.220.30.320.610.820.680.720.630.4-0.460.440.14-0.590.10.570.62
0.680.030.10.410.54-0.64-0.74-0.380.79-0.210.64-0.170.920.730.890.880.630.67-0.390.12-0.25-0.450.560.170.76
1.00.350.040.880.73-0.85-0.66-0.150.82-0.190.99-0.180.70.50.730.690.40.67-0.50.34-0.13-0.520.090.050.72
-0.47-0.73-0.42-0.3-0.610.440.7-0.32-0.410.84-0.48-0.12-0.29-0.28-0.31-0.65-0.46-0.39-0.5-0.120.320.970.460.16-0.44
0.360.230.220.220.67-0.04-0.4-0.2-0.010.350.280.190.280.420.340.280.440.120.34-0.120.21-0.18-0.270.310.39
-0.11-0.49-0.15-0.17-0.060.31-0.02-0.47-0.320.49-0.180.10.030.310.12-0.110.14-0.25-0.130.320.210.21-0.050.220.1
-0.49-0.67-0.41-0.26-0.640.430.8-0.17-0.410.78-0.47-0.26-0.4-0.46-0.43-0.73-0.59-0.45-0.520.97-0.180.210.390.12-0.55
0.13-0.64-0.290.04-0.23-0.16-0.03-0.510.320.380.1-0.270.540.330.480.240.10.560.090.46-0.27-0.050.390.20.26
0.07-0.170.6-0.210.17-0.050.0-0.10.080.210.00.120.110.290.190.060.570.170.050.160.310.220.120.20.05
0.720.20.010.440.69-0.47-0.9-0.530.52-0.10.650.00.860.820.860.90.620.760.72-0.440.390.1-0.550.260.05
Click cells to compare fundamentals

Oncolytics Biotech Account Relationship Matchups

Oncolytics Biotech fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets34.3M45.9M37.3M38.8M44.6M30.5M
Short Long Term Debt Total402.1K654.8K373K423K486.5K301.2K
Total Current Liabilities2.7M2.7M3.9M4.2M4.9M3.9M
Total Stockholder Equity24.8M36.1M26.5M27.6M24.8M17.8M
Property Plant And Equipment Net609.1K976.3K652K647K582.3K460.6K
Net Debt(30.8M)(40.6M)(11.3M)(34.5M)(31.0M)(29.5M)
Retained Earnings(367.1M)(393.4M)(418.3M)(446.0M)(401.4M)(381.3M)
Accounts Payable1.8K594K2.3M1.1M1.2M1.2M
Cash31.2M41.3M11.7M34.9M40.1M42.2M
Non Current Assets Total609.1K976.3K1.7M647K582.3K553.2K
Cash And Short Term Investments31.2M41.3M32.1M34.9M40.1M26.6M
Net Receivables89.7K866.1K521K15K17.3K16.4K
Common Stock Shares Outstanding40.3M53.5M58.0M67.6M77.8M81.7M
Liabilities And Stockholders Equity34.3M45.9M37.3M38.8M44.6M30.5M
Non Current Liabilities Total6.9M7.1M6.9M7.0M8.1M8.5M
Other Current Assets2.4M2.8M3.0M3.2M3.7M3.9M
Other Stockholder Equity31.0M34.2M40.1M42.1M48.4M42.9M
Total Liab9.6M9.8M10.8M11.3M12.9M13.6M
Property Plant And Equipment Gross609.1K976.3K652K1.3M1.5M1.6M
Total Current Assets33.7M44.9M35.7M38.2M43.9M28.0M
Accumulated Other Comprehensive Income400.2K387.7K662K544K489.6K465.1K
Short Term Investments30.4M1.4M20.5M3.4M3.0M2.9M
Short Term Debt248.9K294K216K133K119.7K113.7K
Other Current Liab2.5M1.8M1.5M3.0M3.5M3.2M
Common Stock356.8M391.3M404.0M430.9M495.5M310.7M
Net Tangible Assets(107.9K)24.8M36.1M26.5M30.5M19.0M
Property Plant Equipment727.5K609.1K976.3K652K749.8K610.4K
Capital Surpluse33.0M34.6M37.8M40.1M46.1M35.9M
Long Term Debt Total166.4K153.2K361.1K157K180.6K131.6K
Cash And Equivalents1.1M858.0K1.4M11.7M13.4M14.1M
Current Deferred Revenue(3.2K)(1.8K)(594K)(1.1M)(973.8K)(925.1K)
Net Invested Capital24.8M36.1M26.5M27.6M31.7M20.3M
Net Working Capital31.0M42.2M31.7M33.9M39.0M26.6M
Capital Stock356.8M391.3M404.0M430.9M495.5M399.6M
Capital Lease Obligations402.1K654.8K373K423K380.7K377.5K

Pair Trading with Oncolytics Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Oncolytics Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will appreciate offsetting losses from the drop in the long position's value.

Moving against Oncolytics Stock

  0.67TD Toronto Dominion Bank Earnings Call This WeekPairCorr
  0.62LOU Lucero Energy CorpPairCorr
  0.49GOOG Alphabet CDRPairCorr
  0.37TD-PFD Toronto Dominion Bank Earnings Call This WeekPairCorr
  0.34CAE CAE IncPairCorr
The ability to find closely correlated positions to Oncolytics Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Oncolytics Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Oncolytics Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Oncolytics Biotech to buy it.
The correlation of Oncolytics Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Oncolytics Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Oncolytics Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Oncolytics Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Oncolytics Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oncolytics Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oncolytics Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oncolytics Biotech Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Please note, there is a significant difference between Oncolytics Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Oncolytics Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oncolytics Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
News Freq…Investor S…